Showing results (131-140 of 152) with videos related to

Sort By:
Pageof 16
European Journal of Gynaecological Oncology|May 23, 2012
Evaluation of E6 and E7 mRNA expression in HPV DNA positive breast cancerA Frega, L Lorenzon, M Bononi, et al.
Breast Cancer Research and Treatment|May 18, 1999
Effect of fenretinide on bone mineral density and metabolism in women with early breast cancerA Decensi, R Torrisi, A Gozza, et al.
British Journal of Cancer|October 23, 2008
Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activityR Torrisi, V Bagnardi, A Cardillo, et al.
Breast Cancer Research and Treatment|January 5, 2002
Effect of low dose tamoxifen on the insulin-like growth factor system in healthy womenB Bonanni, H Johansson, S Gandini, et al.
British Journal of Cancer|August 23, 2007
Antitumour and biological effects of letrozole and GnRH analogue as primary therapy in premenopausal women with ER and PgR positive locally advanced operable breast cancerR Torrisi, V Bagnardi, G Pruneri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 17, 2009
A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancerM Colleoni, V Bagnardi, N Rotmensz, et al.
British Journal of Cancer|May 29, 2008
Factors that predict early treatment failure for patients with locally advanced (T4) breast cancerE Montagna, V Bagnardi, N Rotmensz, et al.
AIDS Research and Human Retroviruses|October 9, 1999
The benign cystic lymphoepithelial lesion of the parotid gland is a viral reservoir in HIV type 1-infected patientsS Uccini, E Riva, G Antonelli, et al.
Journal of Cellular Biochemistry|January 5, 2000
Assessment of DNA flow cytometry as a surrogate end point biomarker in a bladder cancer chemoprevention trialS Bruno, R Torrisi, M Costantini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2006
Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative diseaseM Colleoni, N Rotmensz, G Peruzzotti, et al.
Pageof 16